About US
Specializing in the research and development of peptides, recombinant proteins, genetically engineered antibodies, recombinant vaccines, and macromolecular protein drugs
Suzhou PLD Technology Co., Ltd.
Suzhou PLD Technology Co., Ltd. specializes in cell-free protein synthesis technology, dedicated to accelerating the development of novel biopharmaceuticals, personalized medicines, and advanced diagnostic tools through this pioneering platform. Leveraging its expertise, Suzhou PLD Technology enables the swift and efficient production of intricate proteins in a controlled setting, precisely tailored to meet specific therapeutic and diagnostic requirements. Our sophisticated facilities and groundbreaking technologies form a solid basis for conducting high-quality research and guaranteeing the reliability and safety of our products. The company offers a comprehensive suite of cell-free protein expression tools, protein reagents, and customized services tailored to biomedical enterprises and research institutions.
The company was established in
Registered capital
Leading Enterprises in Suzhou Park
Specialized cell-free protein expression biotechnology company
Development planning and vision
Corporate Spirit
We strive to extend our reach to the midstream and downstream segments of the industrial chain. In the fields of protein therapeutics including antibodies, enzyme preparations, cytokines and polypeptides,
Business Philosophy
we will build high-standard corporate laboratories and establish factory-scale high-throughput capabilities for cell-free protein production.
Service Philosophy
We conduct R&D and manufacturing of rare proteins and traditionally hard-to-produce proteins, realizing high-end intelligent manufacturing of pharmaceutical proteins.
Existing patent
The company has obtained dozens of patents, and its capacity for independent innovation continues to strengthen.
Continuous R&D
Continuous investment in technology research and development: layout of nanobodies, bispecific antibodies and anti-tumor, antiviral and other protein drug development platform, the relevant patents are being organized to declare.
Technical Capability
The reaction scale can be expanded as needed; the cell-free protein production level can reach 2-5g/L; the protein that regular cells are difficult to produce can be expressed.
Contact Information
Service Hotline: +86-512-67900128
Customer Service: order@sz-pld.tech
Business Cooperation: bd@sz-pld.tech
Address: Room 302, Building 1, Weili Medical Science and Technology Park, No. 69 Jiepu Road, Suzhou Industrial Park
